Education
About Us
Working with TipRanks
Follow Us
Stem Cell Authority (SCAL)
:SCAL
SCAL Stock Chart & Stats
Day’s Range― - ―
52-Week Range$0.01 - $0.03
Previous CloseN/A
Volume1.00K
Average Volume (3M)10.00K
Market Cap
N/A
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta-3.78
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding87,120,000
10 Day Avg. Volume10,000
30 Day Avg. Volume10,000
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)0.00
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
SCAL FAQ
What was Stem Cell Authority ’s price range in the past 12 months?
Stem Cell Authority lowest stock price was $0.01 and its highest was $0.03 in the past 12 months.
What is Stem Cell Authority ’s market cap?
Currently, no data Available
When is Stem Cell Authority ’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Stem Cell Authority ’s earnings last quarter?
Currently, no data Available
Is Stem Cell Authority overvalued?
According to Wall Street analysts Stem Cell Authority ’s price is currently Overvalued.
Does Stem Cell Authority pay dividends?
Stem Cell Authority does not currently pay dividends.
What is Stem Cell Authority ’s EPS estimate?
Stem Cell Authority ’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Stem Cell Authority have?
Stem Cell Authority has 87,120,000 shares outstanding.
What happened to Stem Cell Authority ’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Stem Cell Authority ?
Currently, no hedge funds are holding shares in SCAL
Company Description
Stem Cell Authority
Stem Cell Authority, Ltd., a technology development company, focuses on the collection and cryogenic preservation of stem cells. It specializes in the collection and cryogenic preservation of the hematopoietic stem cells from the umbilical cord blood; and the Miracle Mesenchymal stem cells from the Wharton's jelly inside the umbilical cord of a newborn child. The company's technology enables birthing professionals with a stem cell preservation program to serve their maternity patients in the United States. Stem Cell Authority, Ltd. is based in Fairlawn, Ohio.
Technical Analysis
Eterna Therapeutics
―
VivoSim Labs
―
Brainstorm Cell Therapeutics
―
Galecto
―
Ocean Biomedical
―